19 results
8-K
EX-3.1
HEPA
Hepion Pharmaceuticals Inc
10 May 23
Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split
5:17pm
8-K
EX-3.2
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-3.3
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-3.4
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-3.1
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-3.1
umtqb
23 Aug 21
Amendments to Articles of Incorporation or Bylaws
9:19am
8-K
EX-3.1
kft4569sc vuua
23 Jul 19
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
EX-3.1
3hkc v21jdoqv6wv
20 Jun 19
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
4:30pm
8-K
EX-3.1
bwz30 uwrh7xs62n
31 May 19
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
8:30am
8-K
EX-3.1
k54 mjehgt7ypw5e
8 May 19
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
EX-3.1
s1ysd
5 Jul 18
Material Modifications to Rights of Security Holders
4:03pm
8-K
EX-3.1
r0a2q eqhqxktz
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm
8-K
EX-3.1
cyp5dh
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
8-K
EX-3.1
ozvj1jnowj1ed auinl
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
10-12G
EX-3.2
a1j3ecklaqdfavedtt
8 Aug 13
Registration of securities
12:00am
10-12G
EX-3.1
oh8wvds x55y6vndin
8 Aug 13
Registration of securities
12:00am
- Prev
- 1
- Next